Review
Accepted on 13 Aug 2025
Neurotrophic Factors in Multiple Sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1654603
- 107 views
Type at least 3 characters
1,412 articles
Review
Published on 13 Aug 2025
Homer-3 antibody in autoimmune cerebellar syndromes: a potentially treatable mimic of MSA-C – A review
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1660587
- 295 views
Editorial
Accepted on 12 Aug 2025
Editorial: 'The Use of Big Data and Artificial Intelligence in Multiple Sclerosis'
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1679482
- 365 views
Systematic Review
Accepted on 12 Aug 2025
Effects of breathing training on walking ability and quality of life in patients with multiple sclerosis: systematic review and meta-analysis of randomized controlled trials
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1643938
- 151 views
Review
Accepted on 11 Aug 2025
Neuro-immune interactions in coronary microvascular disease : Mechanisms and Therapeutic Prospect
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1631083
- 207 views
Original Research
Published on 07 Aug 2025
Identification of cellular factors associated with inflammation and neurodegeneration in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1648725
- 627 views
Editorial
Published on 07 Aug 2025
Editorial: Microglia and tissue macrophages in pain
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1666972
- 354 views
Original Research
Accepted on 05 Aug 2025
Natalizumab and fumarate treatment differentially modulate CD4+ T cell and B cell subtypes in multiple sclerosis patients without impacting durable COVID-19 vaccine responses
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1568157
- 252 views
Original Research
Accepted on 01 Aug 2025
Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1640607
- 165 views
Review
Published on 01 Aug 2025
Immunological microenvironment and targeted therapeutics in multiple sclerosis: new insights in crosstalk between immune niches and CNS
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1604987
- 755 views
Original Research
Accepted on 31 Jul 2025
Discovery and Early Validation of Serum Protein Signatures in untreated Multiple Sclerosis patients: Identification of Candidate Biomarkers for Diagnosis and Stratification
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1579045
- 178 views
Review
Accepted on 31 Jul 2025
Bidirectional Crosstalk Between Microglia and Serotonin Signaling in Neuroinflammation and CNS Disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1646740
- 229 views
Original Research
Published on 30 Jul 2025
Multi-omics exploration of chaperone-mediated immune-proteostasis crosstalk in vascular dementia and identification of diagnostic biomarkers
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1615540
- 846 views
Original Research
Accepted on 29 Jul 2025
GM-CSF production by immune cells in steady state and autoimmune neuroinflammation mapped using fate reporting mice
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1617074
- 169 views
Original Research
Published on 24 Jul 2025
Reduced tolerogenic factor sCD83 in NMOSD and relapsing MOGAD: a potential new therapeutic pathway
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1620069
- 1,353 views
Original Research
Published on 24 Jul 2025
Clinical characteristics of patients with GFAP-IgG coexisting with AQP4-IgG or MOG-IgG
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1610486
- 889 views